Table 2 Bone marrow examination in six COVID-19 patients.
From: Dysregulated hematopoiesis in bone marrow marks severe COVID-19
Cell types (%) | M1 | M2 | M3 | S1 | S2 | S3 | ||
|---|---|---|---|---|---|---|---|---|
Promyelocyte (RR: 0.97–2.17) | 1.50 | – | – | – | 1.50 | – | ||
Neutrophil-myelocyte (RR: 4.45–8.53) | 7.50 | 6.00 | 7.80 | 1.50 | 3.50 | – | ||
Neutrophil-metamyelocyte (RR: 5.93–9.87) | 11.50 | 7.00 | 12.50 | 4.50 | 10.50 | – | ||
Banded neutrophil (RR: 20.22–27.20) | 18.00 | 8.50 | 17.00 | 18.50 | 18.50 | 6.00 | ||
Segmented neutrophil (RR: 6.52–12.36) | 14.50 | 33.00 | 10.30 | 43.50 | 20.50 | 70.00 | ||
Eosinophil-myelocyte (RR: 0.15–0.61) | 0.50 | – | – | – | – | – | ||
Eosinophil-metamyelocyte (RR: 0.17–0.81) | 1.00 | – | 0.50 | – | – | – | ||
Banded eosinophil (RR: 0.64–1.86) | 0.50 | – | – | – | 0.50 | – | ||
Segmented eosinophil (RR: 0.25–1.47) | – | 1.00 | 2.00 | 7.00 | 0.50 | 1.00 | ||
Prorubricyte (RR: 0.51–1.33) | 2.00 | 1.00 | 1.30 | – | 2.50 | – | ||
Rubricyte (RR: 5.50–9.32) | 12.50 | 5.50 | 4.50 | 0.50 | 9.50 | – | ||
Metarubricyte (RR: 8.39–13.11) | 19.00 | 16.50 | 33.50 | 1.50 | 13.00 | – | ||
Mature lymphocyte (RR: 15.74–29.82) | 9.00 | 17.50 | 9.50 | 15.00 | 14.50 | 18.00 | ||
Mature monocyte (RR: 0.00–3.00) | 1.50 | 3.50 | 0.80 | 8.00 | 3.00 | 5.00 | ||
Mature plasma cell (RR: 0.00–0.71) | 1.00 | 0.50 | 0.30 | – | 2.00 | – | ||
Total granulocyte (RR: 40.00–60.00) | 55.00 | 55.50 | 50.20 | 75.00 | 55.50 | 77.00 | ||
Total erythrocyte (RR: 20.00–25.00) | 33.50 | 23.00 | 39.20 | 2.00 | 25.00 | 0.00 | ||
Erythrocyte/nucleated cell ratio | 0.50 | 0.30 | 0.64 | 0.02 | 0.33 | 0.00 | ||
